Page last updated: 2024-10-23

astemizole and Adenocarcinoma of Lung

astemizole has been researched along with Adenocarcinoma of Lung in 1 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chatziantoniou, A1
Zaravinos, A1

Other Studies

1 other study available for astemizole and Adenocarcinoma of Lung

ArticleYear
Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Lung Cancer.
    International journal of molecular sciences, 2022, Sep-18, Volume: 23, Issue:18

    Topics: Adenocarcinoma of Lung; Astemizole; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms;

2022